Amicable M&A possibility exposed to multinational corporation

Published: 1998-03-04 10:44:00

Updated: 1998-03-04 10:44:00

Korea government eliminated restrictive provisions in stock markets, allowing foreigners to purchase up to 55% shares of a domestic firm, which provides many ossibilities for domestic pharmaceutical companies to be merged and acquired by foreign capitals. It was known that an M&A with ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK